Search company, investor...

SHL Telemedicine

shl-telemedicine.com

Founded Year

1987

Stage

IPO | IPO

Date of IPO

11/1/2000

Market Cap

0.24B

About SHL Telemedicine

SHL Telemedicine develops and markets personal telemedicine systems and provides medical call center services to patients. The company`s telemedicine systems are designed to benefit individuals who want or need to take an active role in maintaining their physical health. SHL's telemedicine systems utilize (i) portable, user-friendly monitoring devices capable of transmitting medical data via telecommunications, (ii) hardware and/or software installed in medical call centers which receive transmitted data and store it in a continuously updated patient database and may utilize (iii) Internet technology that allows patients, their physicians and other authorized personnel online access to selected personal medical data via the world wide web.

Headquarters Location

90 Yigal Alon St.

Tel Aviv, 67891,

Israel

+972-3-5612212

Missing: SHL Telemedicine's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SHL Telemedicine's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing SHL Telemedicine

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SHL Telemedicine is included in 3 Expert Collections, including Telehealth.

T

Telehealth

2,854 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health Monitoring & Diagnostics

842 items

Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics

H

Health IT

980 items

SHL Telemedicine Patents

SHL Telemedicine has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/20/2013

12/22/2015

Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Cardiac procedures, Electrophysiology

Grant

Application Date

11/20/2013

Grant Date

12/22/2015

Title

Related Topics

Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Cardiac procedures, Electrophysiology

Status

Grant

Latest SHL Telemedicine News

SHL Telemedicine : announces invitation to an Annual General Meeting

Nov 17, 2022

11/17/2022 | 03:09am EST Message : SHL announces invitation to an Annual General Meeting Tel Aviv / Zurich, 17 November, 2022 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, today announces that an Annual General Meeting (AGM) of the Shareholders will be held on December 22, 2022 at 13:00 (Israel Time), at the Company's registered office, located at 90 Yigal Alon Street, Ashdar Building, Tel Aviv, Israel. The agenda shall include the following matters: Presentation and discussion of the Company's financial statements for the fiscal year ending December 31, 2021, as approved by the Board of Directors of the Company (the "Board") on April 13, 2022. No resolution is required with respect to this item. The re-appointment of Kost, Forer, Gabbay & Kasierer (members of Ernst & Young Global) as the external auditors of the Company until the next Annual General Meeting of the Company, and authorization to the Board to determine the terms and conditions of their engagement, including, inter alia, the remuneration of such external auditors. The re-election to the Board of the current directors of the Company (excluding the external directors who have been elected for a term of 3 years each), who shall serve as directors of the Company until the next Annual General Meeting of the shareholders of the Company. The aforesaid current directors are: (1) Mr. Yariv Alroy, (2) Mr. Ehud Barak, (3) Mr. David Salton, (4) Prof. Amir Lerman, (5) Mr. Erez Nachtomy, and (6) Mr. Erez Alroy. The vote with respect to each of the candidates shall be conducted separately. All of the above as more fully set forth in the Notice to Shareholders available on the Company's website. The record date was set for November 24, 2022. One or more shareholders holding shares representing at least one percent (1%) of the voting rights at the General Meeting may request the Board, in writing, not later than seven (7) days from the date of the invitation to the Annual General Meeting, to include an item on the agenda of the Annual General Meeting to be held. Such item shall be included on the Annual General Meeting's agenda, provided that the Board found it to be suitable for discussion at the Annual General Meeting. Should there be any changes in the agenda of the Annual General Meeting due to such shareholder's request, amended ballot and notice shall be available on the Company's website at https://www.shl-telemedicine.com/general-meeting/ not later than fourteen (14) days from the date of the invitation to the Annual General Meeting. 1/2 The invitation to the AGM shall not be published in newspapers. The full invitation to the AGM can be downloaded on https://www.shl-telemedicine.com/general-meeting/ . Further information About SHL Telemedicine SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No. : 1128957). For more information, please visit our web site at www.shl-telemedicine.com . Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward- looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements. 2/2

SHL Telemedicine Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

SHL Telemedicine Rank

SHL Telemedicine Frequently Asked Questions (FAQ)

  • When was SHL Telemedicine founded?

    SHL Telemedicine was founded in 1987.

  • Where is SHL Telemedicine's headquarters?

    SHL Telemedicine's headquarters is located at 90 Yigal Alon St., Tel Aviv.

  • What is SHL Telemedicine's latest funding round?

    SHL Telemedicine's latest funding round is IPO.

  • Who are the investors of SHL Telemedicine?

    Investors of SHL Telemedicine include Vertex Ventures Israel.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.